Shingo Takikawa

426 total citations
8 papers, 366 citations indexed

About

Shingo Takikawa is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Shingo Takikawa has authored 8 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Epidemiology and 1 paper in Infectious Diseases. Recurrent topics in Shingo Takikawa's work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (2 papers). Shingo Takikawa is often cited by papers focused on Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (2 papers). Shingo Takikawa collaborates with scholars based in United States, Denmark and Japan. Shingo Takikawa's co-authors include Jens Bukh, Suzanne U. Emerson, Robert H. Purcell, Ronald E. Engle, Jean‐Christophe Meunier, Kristina Faulk, Rodney S. Russell, Koji Ishii, Tetsuro Suzuki and Hitoshi Asakura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Journal of General Virology.

In The Last Decade

Shingo Takikawa

8 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shingo Takikawa United States	6	304	262	110	49	48	8	366
Sylvie Trassard France	6	295 1.0×	295 1.1×	60 0.5×	87 1.8×	25 0.5×	6	405
Lisa N. Wasilewski United States	8	279 0.9×	216 0.8×	193 1.8×	54 1.1×	65 1.4×	8	342
Olivier Vidalin France	8	306 1.0×	249 1.0×	42 0.4×	69 1.4×	48 1.0×	8	413
Ophélia Granio France	8	198 0.7×	170 0.6×	46 0.4×	111 2.3×	37 0.8×	9	348
Ermei Yao United States	8	299 1.0×	262 1.0×	35 0.3×	55 1.1×	57 1.2×	11	371
Stefanie Grethe Germany	7	485 1.6×	421 1.6×	62 0.6×	37 0.8×	31 0.6×	10	544
Anna E. Snider United States	7	436 1.4×	339 1.3×	240 2.2×	46 0.9×	96 2.0×	10	485
Maki Kojima Japan	5	430 1.4×	345 1.3×	80 0.7×	22 0.4×	31 0.6×	8	460
Takahide Nakazawa Japan	8	551 1.8×	440 1.7×	116 1.1×	46 0.9×	38 0.8×	8	562
M.C. Jung Germany	11	435 1.4×	333 1.3×	66 0.6×	57 1.2×	58 1.2×	18	539

Countries citing papers authored by Shingo Takikawa

Since Specialization

Citations

This map shows the geographic impact of Shingo Takikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Takikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Takikawa more than expected).

Fields of papers citing papers by Shingo Takikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Takikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Takikawa. The network helps show where Shingo Takikawa may publish in the future.

Co-authorship network of co-authors of Shingo Takikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Takikawa. A scholar is included among the top collaborators of Shingo Takikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Takikawa. Shingo Takikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Russell, Rodney S., Kazunori Kawaguchi, Jean‐Christophe Meunier, et al.. (2009). Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell‐culture‐derived H77/JFH1 chimeric infectious virus particles. Journal of Viral Hepatitis. 16(9). 621–632. 25 indexed citations

Takikawa, Shingo, Ronald E. Engle, Kristina Faulk, et al.. (2009). Molecular evolution of GB virus B hepatitis virus during acute resolving and persistent infections in experimentally infected tamarins. Journal of General Virology. 91(3). 727–733. 19 indexed citations

Russell, Rodney S., Jean‐Christophe Meunier, Shingo Takikawa, et al.. (2008). Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proceedings of the National Academy of Sciences. 105(11). 4370–4375. 143 indexed citations

Sakai, Akito, Shingo Takikawa, Robert Thimme, et al.. (2007). In Vivo Study of the HC-TN Strain of Hepatitis C Virus Recovered from a Patient with Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) Are Infectious in Chimpanzees but Not in Huh7.5 Cells. Journal of Virology. 81(13). 7208–7219. 43 indexed citations

Takikawa, Shingo, Ronald E. Engle, Suzanne U. Emerson, et al.. (2006). Functional analyses of GB virus B p13 protein: Development of a recombinant GB virus B hepatitis virus with a p7 protein. Proceedings of the National Academy of Sciences. 103(9). 3345–3350. 22 indexed citations

Takikawa, Shingo, Yoshiharu Matsuura, & Takuto Miyamura. (2001). [The present studies of the development of HCV vaccine].. PubMed. 59(7). 1379–83. 1 indexed citations

Takikawa, Shingo, Hideki Aizaki, Tetsuro Suzuki, et al.. (2000). Cell Fusion Activity of Hepatitis C Virus Envelope Proteins. Journal of Virology. 74(11). 5066–5074. 4 indexed citations

Takikawa, Shingo, Koji Ishii, Hideki Aizaki, et al.. (2000). Cell Fusion Activity of Hepatitis C Virus Envelope Proteins. Journal of Virology. 74(11). 5066–5074. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact